Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. namibia
  4. solid tumors
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Africa
  • Namibia
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Environmental
Employees

  • Over 1000
  • 101-1000

Solid Tumors Suppliers Serving Namibia

53 companies found
Serving NamibiaNear Namibia

Sequoia Vaccines, Inc.

Sequoia Vaccines, Inc.

based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia - Model SQ1274 - Anticancer Compound

Sequoia - Model SQ1274 - Anticancer Compound

Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
CONTACT SUPPLIER

AbelZeta Inc.

AbelZeta Inc.

based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Model C-CAR031 - Solid Tumors

Model C-CAR031 - Solid Tumors

PRODUCT: C-CAR031. INDICATION: HCC. PLATFORM: CAR-T. PRECLINICAL: GPC3. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
CONTACT SUPPLIER

Oxford Gene Technology IP Limited

Oxford Gene Technology IP Limited

based inOxford, UNITED KINGDOM
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, ...
CONTACT SUPPLIER

Ibio, Inc.

Ibio, Inc.

based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
CONTACT SUPPLIER

Transgene

Transgene

based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
CONTACT SUPPLIER

Sumitomo Pharma Oncology, Inc.

Sumitomo Pharma Oncology, Inc.

based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Sumitomo - Model DSP-7888 - Ombipepimut-S Emulsion  WT1 Immunotherapeutic Cancer Vaccine

Sumitomo - Model DSP-7888 - Ombipepimut-S Emulsion WT1 Immunotherapeutic Cancer Vaccine

Ombipepimut-S Emulsion (DSP-7888) is an investigational immunotherapeutic cancer vaccine containing 2 peptides that induce WT1-specific cytotoxic T lymphocytes (WT1-CTLs) and helper T cells to attack WT1-expressing cancerous cells found in various ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTengine - Next-generation Enhancement Strategies

ACTengine - Next-generation Enhancement Strategies

Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the ...
CONTACT SUPPLIER

EirGenix, Inc

EirGenix, Inc

based inNew Taipei City, TAIWAN
For EirGenix Inc., health is important for all people. Under this belief, EirGenix established two business units to achieve the goal. One is contract development and manufacturing operation unit where EirGenix helps clients to manufacture their ...
CONTACT SUPPLIER

Miltenyi Biotec B.V. & Co. KG

Miltenyi Biotec B.V. & Co. KG

based inBergisch Gladbach, GERMANY
For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy. Our expertise spans ...
CONTACT SUPPLIER

Biozol GmbH

Biozol GmbH

based inEching,, GERMANY
BIOZOL - World of Science distribution service. We provide you more than 25 Million products of more than 260 partner companies around the world. For our customers we overcome national borders, customs and import regulations. So, you receive for ...
CONTACT SUPPLIER

Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co., Ltd.

based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
CONTACT SUPPLIER

Elpiscience

Elpiscience

based inShanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
Model ES028 - Bispecific Macrophage Engager (BiME) Platform

Model ES028 - Bispecific Macrophage Engager (BiME) Platform

The SIRPα antibody blocks the “don’t-eat-me” signal while the TAA antibody provides an “eat-me” signal through Fc receptor engagement. ES028 and the BiME platform are designed for potent activation of phagocytosis ...
CONTACT SUPPLIER

Eutilex Co.,Ltd.

Eutilex Co.,Ltd.

based inSeoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
CONTACT SUPPLIER

SystImmune Inc.

SystImmune Inc.

based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
SystImmune - Model SI-B003 - Tetravalent

SystImmune - Model SI-B003 - Tetravalent

The tetravalent SI-B003 has two binding domains for T cell checkpoint axis, PD-1 and CTLA-4. The primary targets for this molecule are exhausted tumor-specific T cells which demonstrate enhanced functionality upon treatment with ...
CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-008 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

Elicio - Model ELI-008 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

ELI-008 is a multivalent lymph node–targeted AMP peptide vaccine developed to target p53 hotspot mutations. p53 is a tumor-suppressing protein that controls the cell cycle, DNA replication, and uncontrolled ...
CONTACT SUPPLIER

Kailos Genetics, LLC.

Kailos Genetics, LLC.

based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
CONTACT SUPPLIER

The Menarini Group

The Menarini Group

based inFlorence, ITALY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...
Model MEN1309 - Antibody-Drug Conjugate (ADC)

Model MEN1309 - Antibody-Drug Conjugate (ADC)

MEN1309 is an antibody-drug conjugate (ADC) constituted by a fully human IgG1 antibody conjugated through a cleavable linker to a cytotoxic agent (a maytansin derivative, DM4), responsible for its antitumor activity. The target antigen, CD205, is ...
CONTACT SUPPLIER

OncoDNA S.A.

OncoDNA S.A.

based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
CONTACT SUPPLIER

Jubilant Therapeutics Inc.

Jubilant Therapeutics Inc.

based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Model LSD1/HDAC6 - Cancer Stem Cell

Model LSD1/HDAC6 - Cancer Stem Cell

Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
CONTACT SUPPLIER

MedChemExpress LLC (MCE)

MedChemExpress LLC (MCE)

based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MedChemExpress - Model Lixumistat acetate - 1422365-94-3

MedChemExpress - Model Lixumistat acetate - 1422365-94-3

Lixumistat (acetate) is a potent oxidative phosphorylation (OXPHOS) inhibitor which can be used for the research of solid ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT